1. P288 Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn's Disease. (27th May 2021) Authors: Macaluso, F S; Cappello, M; Crispino, F; Grova, M; Privitera, A C; Piccillo, G; Magnano, A; Ferracane, C; Belluardo, N; Giangreco, E; Fries, W; Viola, A; Di Mitri, R; Mocciaro, F; Camilleri, S; Garufi, S; Renna, S; Casà, A; Maida, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P436 SPOSAB ABP 501 - A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501. (27th May 2021) Authors: Macaluso, F; Cappello, M; Busacca, A; Fries, W; Viola, A; Costantino, G; Magnano, A; Vinci, E; Ferracane, C; Privitera, A C; Piccillo, G; Belluardo, N; Giangreco, E; Romano, C; Citrano, M; Graziano, F; Garufi, S; Bertolami, C; Scrivo, B; Renna, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P439 Effectiveness of Ustekinumab on Crohn's disease associated spondyloartropathy: real-world data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD). (27th May 2021) Authors: Macaluso, F; Fries, W; Viola, A; Costantino, G; Muscianisi, M; Cappello, M; Guida, L; Giuffrida, E; Magnano, A; Pluchino, D; Ferracane, C; Magrì, G; Di Mitri, R; Mocciaro, F; Privitera, A C; Camilleri, S; Garufi, S; Renna, S; Casà, A; Scrivo, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P644 Effectiveness of vedolizumab on intestinal outcomes and articular manifestations: Real-world data from the Sicilian Network for inflammatory bowel disease (SN-IBD). (16th January 2018) Authors: Macaluso, F S; Orlando, R; Fries, W; Scolaro, M; Magnano, A; Pluchino, D; Cappello, M; Morreale, G C; Siringo, S; Privitera, A C; Ferracane, C; Belluardo, N; Alberghina, N; Ventimiglia, M; Rizzuto, G; Renna, S; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis. (25th January 2019) Authors: Macaluso, F S; Cappello, M; Giuffrida, E; Fries, W; Centritto, A; Privitera, A C; Inserra, G; Vassallo, R; Magnano, A; Vinci, E; Garufi, S; Ventimiglia, M; Renna, S; Orlando, R; Rizzuto, G; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗